We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$14.7B
AUM Growth
+$562M
Cap. Flow
-$182M
Cap. Flow %
-1.24%
Top 10 Hldgs %
20.54%
Holding
1,679
New
173
Increased
492
Reduced
677
Closed
92

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$58.5M
2
DOCU
DocuSign
DOCU
+$21.3M
3
BKE icon
Buckle
BKE
+$20.9M
4
MSFT icon
Microsoft
MSFT
+$18.4M
5
USFD icon
US Foods
USFD
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Healthcare 17.99%
3 Financials 13.41%
4 Industrials 9.72%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
76
Vanguard High Dividend Yield ETF
VYM
$80.9B
$49.5M 0.34%
595,682
-5,876
-1% -$492K
CL icon
77
Colgate-Palmolive
CL
$73.1B
$48.5M 0.33%
748,244
-95,853
-11% -$6.27M
VBK icon
78
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$46.8M 0.32%
266,117
+28,347
+12% +$4.86M
WAB icon
79
Wabtec
WAB
$49.1B
$46.6M 0.32%
473,202
-48,485
-9% -$4.51M
MCD icon
80
McDonald's
MCD
$192B
$46.6M 0.32%
297,669
+34,366
+13% +$5.57M
EVH icon
81
Evolent Health
EVH
$348M
$46M 0.31%
2,184,334
-293,970
-12% -$5.56M
SCHW
82
Charles Schwab
SCHW
$183B
$45.9M 0.31%
897,840
+43,956
+5% +$2.43M
VEA icon
83
Vanguard FTSE Developed Markets ETF
VEA
$229B
$45.8M 0.31%
1,068,245
+10,984
+1% +$490K
MKC icon
84
McCormick & Company Non-Voting
MKC
$13.7B
$44.3M 0.3%
762,906
+10,376
+1% +$545K
XOM icon
85
ExxonMobil
XOM
$644B
$43.2M 0.29%
522,260
-18,371
-3% -$1.46M
EW icon
86
Edwards Lifesciences
EW
$49.6B
$42.8M 0.29%
881,577
-160,209
-15% -$7.48M
MMM icon
87
3M
MMM
$90.9B
$42.5M 0.29%
258,164
+16,900
+7% +$2.88M
PG icon
88
Procter & Gamble
PG
$336B
$42M 0.29%
538,634
-63,740
-11% -$4.8M
BWXT icon
89
BWX Technologies
BWXT
$15.5B
$41.9M 0.29%
673,117
+52,877
+9% +$3.52M
ISRG icon
90
Intuitive Surgical
ISRG
$127B
$41.5M 0.28%
260,361
-1,464
-0.6% -$223K
BAC icon
91
Bank of America
BAC
$435B
$41.5M 0.28%
1,472,508
+36,565
+3% +$1.09M
VTV icon
92
Vanguard Morningstar Value ETF
VTV
$188B
$41M 0.28%
395,307
+10,542
+3% +$1.1M
ESRX
93
DELISTED
Express Scripts Holding Company
ESRX
$39.2M 0.27%
508,147
-36,126
-7% -$2.71M
PLNT icon
94
Planet Fitness
PLNT
$4.42B
$38.7M 0.26%
880,493
+127,583
+17% +$5.23M
CTAS icon
95
Cintas
CTAS
$81.9B
$38M 0.26%
821,704
-2,836
-0.3% -$128K
SLB icon
96
SLB Ltd
SLB
$73.6B
$37.9M 0.26%
565,245
-110,182
-16% -$7.57M
LULU icon
97
lululemon athletica
LULU
$13.5B
$37.9M 0.26%
303,433
-87,018
-22% -$9.28M
EXAS
98
DELISTED
Exact Sciences
EXAS
$37.9M 0.26%
633,377
-31,161
-5% -$1.68M
BMY icon
99
Bristol-Myers Squibb
BMY
$133B
$37.3M 0.25%
674,381
-43,011
-6% -$2.32M
NVDA icon
100
NVIDIA
NVDA
$4.86T
$36.9M 0.25%
6,226,360
-13,400
-0.2% -$81.4K

Similar funds

William Blair & Company's Q2 2018 Portfolio in Review

As of Q2 2018, William Blair & Company held 1,679 positions worth $14.7B, up 4% from $14.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

William Blair & Company's Q2 2018 filing shows 173 new, 492 increased, 677 reduced and 92 closed positions. Its largest new stake was DocuSign: 422,114 shares worth $22.4M. The largest sale was Starbucks, an estimated $47M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2018 buy was DocuSign: 422,114 shares worth $22.4M.
  • William Blair & Company added most to Everpure Inc in Q2 2018, an estimated $58.5M increase.
  • William Blair & Company's biggest Q2 2018 reduction was Starbucks, cutting an estimated $47M.
  • William Blair & Company fully exited Cavium, Inc. in Q2 2018, selling an estimated $9.64M.
  • William Blair & Company's ten largest holdings make up 21% of its $14.7B portfolio in Q2 2018.
  • William Blair & Company opened 173 new positions and closed 92 in Q2 2018.
  • William Blair & Company's portfolio value rose 4% quarter-over-quarter to $14.7B.

Based on William Blair & Company's 13F filing for Q2 2018, filed 13 Aug 2018.